{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T01:30:05Z","timestamp":1786498205087,"version":"build-2736575974"},"reference-count":63,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Obesity disproportionately affects low- and middle-income countries, where access to structured, scalable treatment remains limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate whether a hybrid-format, intensive lifestyle modification program combined with usual medical care promotes a minimum weight loss of 5% in adults with obesity compared with usual medical care alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This open-label, parallel-group, superiority randomized clinical trial recruited adults with a body mass index of 30 or greater from a tertiary public hospital in S\u00e3o Paulo, Brazil, between January 1 and March 31, 2022, randomized 1:1 to PRAMEV (Advanced Program for Intensive Lifestyle Modification) or control. Data were analyzed from May to September 2025 using an intention-to-treat approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>PRAMEV was a 20-week, hybrid lifestyle intervention that included group-based behavioral counseling, nutritional education, physical activity promotion, and continuous instructor support. The control group received usual medical care.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>The primary outcome was the proportion of participants achieving a 5% or greater reduction in body weight assessed by bioelectrical impedance analysis at 20 weeks. Secondary outcomes included changes in weight, body mass index, waist circumference, metabolic parameters (lipid profile, glucose, and liver enzyme levels), dietary intake, and psychosocial variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 200 participants (mean [SD] age, 47.9 [14.0] years; 172 [86.0%] women) were randomized to PRAMEV (n\u2009=\u200997) or control (n\u2009=\u2009103). At 20 weeks, 143 participants (71.4%) completed follow-up, with higher dropout in the PRAMEV arm vs the control arm (39.2% [38 of 97] vs 21.4% [22 of 103];\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.008). In the intention-to-treat analysis, groups did not differ in achieving 5% or greater weight loss (20.6% [20 of 97] vs 15.5% [16 of 103]; odds ratio, 1.34; 95% CI, 0.61-2.92;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u2009.46). Per-protocol analyses showed greater weight loss and improved anthropometric outcomes in the PRAMEV arm. The intervention improved the lipid profile, with reductions in liver enzyme and triglyceride levels and favorable changes in cholesterol fractions. No serious adverse events were reported.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this randomized clinical trial of 200 adults with obesity receiving care in Brazil\u2019s public health care system, a hybrid-format lifestyle intervention did not improve the likelihood of achieving 5% or greater weight loss in the intention-to-treat analysis. However, secondary and per-protocol analyses suggested potential cardiometabolic benefits among adherent participants, warranting further investigation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      ReBEC Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/ensaiosclinicos.gov.br\/rg\/RBR-10wpdd9c\">U1111-1273-8313<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.26884","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:30:16Z","timestamp":1786462216000},"page":"e2626884","source":"Crossref","is-referenced-by-count":1,"title":["A Hybrid Lifestyle Program and Metabolic Health in Adults With Obesity"],"prefix":"10.1001","volume":"9","author":[{"given":"Graziele","family":"Souza de Menezes Amorim Coelho","sequence":"first","affiliation":[{"name":"Grupo de Obesidade e Sindrome Metabolica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariana Ester","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Grupo de Obesidade e Sindrome Metabolica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"},{"name":"Unidade de Medicina Interdisciplinar em Cardiologia, Instituto do Cora\u00e7\u00e3o, Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata Bressan","family":"Pepe","sequence":"additional","affiliation":[{"name":"Grupo de Obesidade e Sindrome Metabolica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Aparecida","family":"Cruz","sequence":"additional","affiliation":[{"name":"Grupo de Obesidade e Sindrome Metabolica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Samara","family":"Audi","sequence":"additional","affiliation":[{"name":"Grupo de Obesidade e Sindrome Metabolica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cintia","family":"Cercato","sequence":"additional","affiliation":[{"name":"Grupo de Obesidade e Sindrome Metabolica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"},{"name":"Laborat\u00f3rio de Lipides (LIM 10), Hospital das Cl\u00ednicas HCFMUSP, Faculdade de Medicina, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio C.","family":"Mancini","sequence":"additional","affiliation":[{"name":"Grupo de Obesidade e Sindrome Metabolica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"},{"name":"Laborat\u00f3rio de Carboidratos e Radioimunoensaios (LIM 18), Faculdade de Medicina FMUSP, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Edna","family":"de Melo","sequence":"additional","affiliation":[{"name":"Grupo de Obesidade e Sindrome Metabolica, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, SP, Brazil"},{"name":"Laborat\u00f3rio de Carboidratos e Radioimunoensaios (LIM 18), Faculdade de Medicina FMUSP, Universidade de S\u00e3o Paulo, S\u00e3o Paulo, SP, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"issue":"10258","key":"zoi260737r2","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","author":"GBD 2019 Risk Factors Collaborators","year":"2020","journal-title":"Lancet"},{"issue":"10456","key":"zoi260737r3","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1016\/S0140-6736(24)01210-8","article-title":"Obesity in adults.","volume":"404","author":"Lingvay","year":"2024","journal-title":"Lancet"},{"issue":"9","key":"zoi260737r4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2022-009773","article-title":"Economic impacts of overweight and obesity: current and future estimates for 161 countries.","volume":"7","author":"Okunogbe","year":"2022","journal-title":"BMJ Glob Health"},{"issue":"3","key":"zoi260737r5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s13679-020-00398-7","article-title":"Socioeconomics of Obesity.","volume":"9","author":"Anekwe","year":"2020","journal-title":"Curr Obes Rep"},{"issue":"11","key":"zoi260737r6","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1001\/jama.2018.7777","article-title":"Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US Preventive Services Task Force.","volume":"320","author":"LeBlanc","year":"2018","journal-title":"JAMA"},{"issue":"5","key":"zoi260737r7","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity.","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterology"},{"issue":"7","key":"zoi260737r8","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1001\/jamainternmed.2023.8526","article-title":"Approach to obesity treatment in primary care: a review.","volume":"184","author":"Yanovski","year":"2024","journal-title":"JAMA Intern Med"},{"issue":"8","key":"zoi260737r9","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/oby.24336","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society.","volume":"33","author":"Mozaffarian","year":"2025","journal-title":"Obesity (Silver Spring)"},{"issue":"20","key":"zoi260737r10","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1001\/jama.2023.19897","article-title":"Obesity management in adults: a review.","volume":"330","author":"Elmaleh-Sachs","year":"2023","journal-title":"JAMA"},{"key":"zoi260737r11","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.2337\/dc24-S008","article-title":"Obesity and weight management for the prevention and treatment of type 2 diabetes: Standards of Care in Diabetes-2024.","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"issue":"4","key":"zoi260737r12","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2337\/diacare.22.4.623","article-title":"The Diabetes Prevention Program: design and methods for a clinical trial in the prevention of type 2 diabetes.","volume":"22","author":"The Diabetes Prevention Program Research Group","year":"1999","journal-title":"Diabetes Care"},{"issue":"5","key":"zoi260737r13","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/oby.2006.84","article-title":"The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it.","volume":"14","author":"Wadden","year":"2006","journal-title":"Obesity (Silver Spring)"},{"issue":"5","key":"zoi260737r14","doi-asserted-by":"publisher","first-page":"777","DOI":"10.2337\/dc18-0836","article-title":"Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: one-year results of the PREDIMED-Plus trial.","volume":"42","author":"Salas-Salvad\u00f3","year":"2019","journal-title":"Diabetes Care"},{"issue":"6","key":"zoi260737r15","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.orcp.2021.10.003","article-title":"Effectiveness to promote weight loss maintenance and healthy lifestyle habits of a group educational intervention program in adults with obesity: IGOBE program.","volume":"15","author":"Porca","year":"2021","journal-title":"Obes Res Clin Pract"},{"issue":"12","key":"zoi260737r16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.27744","article-title":"Effect of a culturally adapted behavioral intervention for Latino adults on weight loss over 2 years: a randomized clinical trial.","volume":"3","author":"Rosas","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"zoi260737r17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0286204","article-title":"Implementation outcomes and strategies for delivering evidence-based hypertension interventions in lower-middle-income countries: evidence from a multi-country consortium for hypertension control.","volume":"18","author":"Gyamfi","year":"2023","journal-title":"PLoS One"},{"key":"zoi260737r19","doi-asserted-by":"publisher","DOI":"10.1590\/0102-311x00051620","article-title":"Is the management of obesity in primary health care appropriate in Brazil?","volume":"37","author":"Lopes","year":"2021","journal-title":"Cad Saude Publica"},{"key":"zoi260737r20","doi-asserted-by":"publisher","DOI":"10.26633\/RPSP.2020.32","article-title":"Costs attributable to obesity, hypertension, and diabetes in the Unified Health System, Brazil, 2018.","author":"Nilson","year":"2020","journal-title":"Rev Panam Salud Publica"},{"key":"zoi260737r21","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1050527","article-title":"Hybrid model of intensive lifestyle intervention is potentially effective in patients with diabetes & obesity for post-COVID era.","volume":"13","author":"Dhaver","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"20","key":"zoi260737r22","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.","volume":"310","author":"World Medical Association","year":"2013","journal-title":"JAMA"},{"issue":"22","key":"zoi260737r23","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1001\/jama.2025.4347","article-title":"CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.","volume":"333","author":"Hopewell","year":"2025","journal-title":"JAMA"},{"issue":"10","key":"zoi260737r25","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.3390\/nu11102324","article-title":"Effectiveness of the Diabetes Prevention Program for obesity treatment in real world clinical practice in a middle-income country in Latin America.","volume":"11","author":"Armenta-Guirado","year":"2019","journal-title":"Nutrients"},{"issue":"22","key":"zoi260737r26","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1001\/jama.2022.21908","article-title":"The challenge of defining the optimal lifestyle weight loss intervention for real-world settings.","volume":"328","author":"Wing","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"zoi260737r27","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1017\/S1368980017000234","article-title":"The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing.","volume":"21","author":"Monteiro","year":"2018","journal-title":"Public Health Nutr"},{"issue":"4","key":"zoi260737r28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1590\/S1516-44462001000400008","article-title":"Tradu\u00e7\u00e3o e adapta\u00e7\u00e3o para o portugu\u00eas da Escala de Compuls\u00e3o Alimentar Peri\u00f3dica.","volume":"23","author":"Freitas","year":"2001","journal-title":"Braz J Psychiatry"},{"key":"zoi260737r29","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jad.2013.10.031","article-title":"Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese.","volume":"155","author":"Vignola","year":"2014","journal-title":"J Affect Disord"},{"issue":"12","key":"zoi260737r30","doi-asserted-by":"publisher","first-page":"2165","DOI":"10.2337\/diacare.25.12.2165","article-title":"The Diabetes Prevention Program (DPP): description of lifestyle intervention.","volume":"25","author":"Diabetes Prevention Program (DPP) Research Group","year":"2002","journal-title":"Diabetes Care"},{"issue":"7","key":"zoi260737r32","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1097\/01.ASN.0000070140.62190.97","article-title":"The diabetes prevention program and its global implications.","volume":"14","author":"Molitch","year":"2003","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"zoi260737r33","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.2337\/dc11-0874","article-title":"Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial.","volume":"34","author":"Unick","year":"2011","journal-title":"Diabetes Care"},{"key":"zoi260737r34","doi-asserted-by":"publisher","DOI":"10.5888\/pcd21.230347","article-title":"Weight loss in short-term interventions for physical activity and nutrition among adults with overweight or obesity: a systematic review and meta-analysis.","volume":"21","author":"Rotunda","year":"2024","journal-title":"Prev Chronic Dis"},{"issue":"3","key":"zoi260737r35","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/jama.281.3.235","article-title":"Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial.","volume":"281","author":"Davidson","year":"1999","journal-title":"JAMA"},{"issue":"10","key":"zoi260737r36","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJMoa1003114","article-title":"Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.","volume":"363","author":"James","year":"2010","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi260737r37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management.","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"issue":"11","key":"zoi260737r38","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/sj.ijo.0802783","article-title":"A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects.","volume":"28","author":"Wilding","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"3","key":"zoi260737r39","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/oby.70127","article-title":"Efficacy of oral antiobesity medications with versus without adjunct behavioral weight management treatment.","volume":"34","author":"Jones","year":"2026","journal-title":"Obesity (Silver Spring)"},{"issue":"20","key":"zoi260737r40","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1056\/NEJMoa050156","article-title":"Randomized trial of lifestyle modification and pharmacotherapy for obesity.","volume":"353","author":"Wadden","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi260737r41","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S2213-8587(17)30292-9","article-title":"Metabolically healthy obesity: the low-hanging fruit in obesity treatment?","volume":"6","author":"Stefan","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"16","key":"zoi260737r42","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/eurjpc\/zwaf308","article-title":"Individual response to lifestyle interventions: a pooled analysis of three long-term weight loss trials.","volume":"32","author":"Yaskolka Meir","year":"2025","journal-title":"Eur J Prev Cardiol"},{"issue":"2","key":"zoi260737r44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41366-024-01632-1","article-title":"Health-enhancing physical activity in obesity management: the need to (seriously) go beyond weight loss.","volume":"49","author":"Oppert","year":"2025","journal-title":"Int J Obes (Lond)"},{"key":"zoi260737r45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jshs.2025.101097","article-title":"Physical activity and exercise within the context of obesity treatment: enhancing health beyond weight loss.","volume":"15","author":"Jakicic","year":"2025","journal-title":"J Sport Health Sci"},{"issue":"9","key":"zoi260737r46","doi-asserted-by":"publisher","first-page":"4981","DOI":"10.3390\/ijerph19094981","article-title":"The benefits of physical activity for people with obesity, independent of weight loss: a systematic review.","volume":"19","author":"Pojednic","year":"2022","journal-title":"Int J Environ Res Public Health"},{"issue":"2771","key":"zoi260737r47","doi-asserted-by":"publisher","first-page":"n2771","DOI":"10.1136\/bmj.n2771","article-title":"Group programmes for weight loss may be more effective than one-to-one sessions.","volume":"375","author":"Saul","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"zoi260737r48","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13063-025-08720-1","article-title":"Effect of group-based nutritional education combined with individual standard care for outpatients with type 2 diabetes: study protocol for a randomized clinical trial 1.","volume":"26","author":"Busanello","year":"2025","journal-title":"Trials"},{"issue":"12","key":"zoi260737r49","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa673","article-title":"Weight loss and serum lipids in overweight and obese adults: a systematic review and meta-analysis.","volume":"105","author":"Hasan","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"zoi260737r50","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1017\/S0007114515002706","article-title":"Prevalence and characteristics of misreporting of energy intake in US adults: NHANES 2003-2012.","volume":"114","author":"Murakami","year":"2015","journal-title":"Br J Nutr"},{"issue":"1","key":"zoi260737r51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12874-025-02568-4","article-title":"Dietary misreporting: a comparative study of recalls vs energy expenditure and energy intake by doubly-labeled water in older adults with overweight or obesity.","volume":"25","author":"Santos-B\u00e1ez","year":"2025","journal-title":"BMC Med Res Methodol"},{"issue":"1","key":"zoi260737r52","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1093\/ajcn\/nqab012","article-title":"Underreporting of energy intake in weight loss maintainers.","volume":"114","author":"Dahle","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"zoi260737r53","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2021.111259","article-title":"Mis-reporting of energy intake among older Australian adults: prevalence, characteristics, and associations with quality of life.","volume":"90","author":"Govindaraju","year":"2021","journal-title":"Nutrition"},{"issue":"6","key":"zoi260737r54","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1038\/oby.2011.140","article-title":"Male inclusion in randomized controlled trials of lifestyle weight loss interventions.","volume":"20","author":"Pagoto","year":"2012","journal-title":"Obesity (Silver Spring)"},{"issue":"2-3","key":"zoi260737r55","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1758-8111.2011.00020.x","article-title":"Decisions about weight management: a synthesis of qualitative studies of obesity.","volume":"1","author":"Brown","year":"2011","journal-title":"Clin Obes"},{"issue":"5","key":"zoi260737r56","doi-asserted-by":"publisher","DOI":"10.1111\/cob.12604","article-title":"Motivations for participation in weight loss clinical trials.","volume":"13","author":"Susanto","year":"2023","journal-title":"Clin Obes"},{"issue":"5","key":"zoi260737r57","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1177\/1557988314567223","article-title":"Gender differences in weight-related attitudes and behaviors among overweight and obese adults in the United States.","volume":"10","author":"Tsai","year":"2016","journal-title":"Am J Mens Health"},{"issue":"2","key":"zoi260737r58","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000468154","article-title":"Impact of weight-related discrimination, body dissatisfaction and self-stigma on the desire to weigh less.","volume":"10","author":"Jung","year":"2017","journal-title":"Obes Facts"},{"issue":"11","key":"zoi260737r59","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1038\/sj.ijo.0803649","article-title":"The role of patients\u2019 expectations and goals in the behavioral and pharmacological treatment of obesity.","volume":"31","author":"Fabricatore","year":"2007","journal-title":"Int J Obes (Lond)"},{"issue":"11","key":"zoi260737r60","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/j.1467-789X.2011.00915.x","article-title":"Predictors of dropout in weight loss interventions: a systematic review of the literature.","volume":"12","author":"Moroshko","year":"2011","journal-title":"Obes Rev"},{"key":"zoi260737r61","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eatbeh.2015.11.009","article-title":"Socio-demographic, anthropometric, and psychosocial predictors of attrition across behavioral weight-loss trials.","volume":"20","author":"Goode","year":"2016","journal-title":"Eat Behav"},{"issue":"1","key":"zoi260737r62","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s11121-013-0451-1","article-title":"Participant and site characteristics related to participant retention in a diabetes prevention translational project.","volume":"16","author":"Jiang","year":"2015","journal-title":"Prev Sci"},{"issue":"9","key":"zoi260737r63","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.2337\/dc19-2366","article-title":"Retention among participants in the national diabetes prevention program lifestyle change program, 2012-2017.","volume":"43","author":"Cannon","year":"2020","journal-title":"Diabetes Care"},{"key":"zoi260737r31","volume-title":"Guia Alimentar para a Popula\u00e7\u00e3o Brasileira","author":"Minist\u00e9rio da Sa\u00fade (Brazil)","year":"2014","edition":"2nd ed"},{"key":"zoi260737r43","volume-title":"Dietary Patterns and Risk of Cardiovascular Disease: A Systematic Review","year":"2020"},{"key":"zoi260737r1","unstructured":"World Health Organization. Obesity and overweight. Accessed August 4, 2025. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"key":"zoi260737r18","unstructured":"Vigitel Brasil 2023: Vigil\u00e2ncia de Fatores de Risco E Prote\u00e7\u00e3o Para Doen\u00e7as Cr\u00f4nicas por Inqu\u00e9rito Telef\u00f4nico: Estimativas Sobre Frequ\u00eancia e Distribui\u00e7\u00e3o Sociodemogr\u00e1fica de Fatores de Risco e Prote\u00e7\u00e3o Para Doen\u00e7as Cr\u00f4nicas Nas Capitais dos 26 Estados Brasileiros e no Distrito Federal em 2023. Minist\u00e9rio da Sa\u00fade; 2023. Accessed June 25, 2026. https:\/\/www.gov.br\/saude\/pt-br\/centrais-de-conteudo\/publicacoes\/svsa\/vigitel\/vigitel-brasil-2023-vigilancia-de-fatores-de-risco-e-protecao-para-doencas-cronicas-por-inquerito-telefonico\/view"},{"key":"zoi260737r24","unstructured":"Instituto Brasileiro de Geografia e Estat\u00edstica. Caracter\u00edsticas \u00c9tnico-Raciais da Popula\u00e7\u00e3o: Classifica\u00e7\u00f5es e Identidades. IBGE; 2013. Accessed June 25, 2026.  https:\/\/biblioteca.ibge.gov.br\/visualizacao\/livros\/liv63405.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852619\/souza_de_menezes_amorim_coelho_2026_oi_260737_1785786146.67398.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:30:18Z","timestamp":1786462218000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852619"}},"subtitle":["The PRAMEV Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.26884","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]}}}